Browse by author
Lookup NU author(s): Dr Richard Fisher,
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2014, Springer-Verlag Berlin Heidelberg. Mutations in ANKRD11 have recently been reported to cause KBG syndrome, an autosomal dominant condition characterized by intellectual disability (ID), behavioral problems, and macrodontia. To understand the pathogenic mechanism that relates ANKRD11 mutations with the phenotype of KBG syndrome, we studied the cellular characteristics of wild-type ANKRD11 and the effects of mutations in humans and mice. We show that the abundance of wild-type ANKRD11 is tightly regulated during the cell cycle, and that the ANKRD11 C-terminus is required for the degradation of the protein. Analysis of 11 pathogenic ANKRD11 variants in humans, including six reported in this study, and one reported in the Ankrd11Yod/+ mouse, shows that all mutations affect the C-terminal regions and that the mutant proteins accumulate aberrantly. In silico analysis shows the presence of D-box sequences that are signals for proteasome degradation. We suggest that ANKRD11 C-terminus plays an important role in regulating the abundance of the protein, and a disturbance of the protein abundance due to the mutations leads to KBG syndrome.
Author(s): Walz K, Cohen D, Neilsen PM, Foster J, Brancati F, Demir K, Fisher R, Moffat M, Verbeek NE, Bjorgo K, Lo Castro A, Curatolo P, Novelli G, Abad C, Lei C, Zhang L, Diaz-Horta O, Young JI, Callen DF, Tekin M
Publication type: Article
Publication status: Published
Journal: Human Genetics
Print publication date: 01/02/2015
Online publication date: 21/11/2014
Acceptance date: 01/01/1900
ISSN (print): 0340-6717
ISSN (electronic): 1432-1203
Publisher: Springer Verlag
PubMed id: 25413698
Altmetrics provided by Altmetric